Published in

Taylor and Francis Group, Acta Oncologica, 12(62), p. 1689-1697, 2023

DOI: 10.1080/0284186x.2023.2254479

Links

Tools

Export citation

Search in Google Scholar

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO